Effect of an Adapted Ice Cream on Cancer patients during Chemotherapy
Not Applicable
Recruiting
- Conditions
- Hematologic Neoplasms. Leukemia. Lymphoma. Squamous Cell Carcinoma of Head and Neck. Esophageal Neoplasms. Facial Neoplasms. Mouth Neoplasms. Parathyroid Neoplasms. Thyroid Neoplasms. Tracheal NeoplasmsC04.588.443
- Registration Number
- RBR-5dvnbqx
- Lead Sponsor
- niversidade Federal de Santa Catarina
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
individuals aged 19 years or over; both sexes; with recent clinical diagnosis of hematologic cancer or head and neck cancer and with indication to start chemotherapy treatment; in conditions of oral ingestion.
Exclusion Criteria
in palliative care; using statins and/or other anti-inflammatory drugs; who have undergone anticancer treatment in the 5 years prior to the survey; diagnosed with infectious contagious diseases; with indication for the use of enteral or parenteral nutrition; who have taken dietary supplements in the 6 months prior to the study; and who have an intolerance or allergy to any component of the adapted ice cream. Pregnant and lactating women will also be excluded.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method